• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oncolytics Biotech Inc

+ Add to Watchlist


0.4700 USD 0.0012 0.25%

As of 17:20:00 ET on 01/27/2015.

Snapshot for Oncolytics Biotech Inc (ONCY)

Open: 0.4697 Day's Range: 0.4400 - 0.4700 Volume: 230,555
Previous Close: 0.4712 52wk Range: 0.4000 - 2.0700 1-Yr Rtn: -72.19%

Stock Chart for ONCY

No chart data available.
  • ONCY:US 0.4420
  • 1D
  • 1M
  • 1Y
Interactive ONCY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONCY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.2540
Est. PEG Ratio -
Market Cap (M USD) 43.15
Shares Outstanding (M) 91.81
30 Day Average Volume 372,183
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONCY

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ONCY

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for ONCY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil